We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ESC 2024 - Pardeep Jhund discusses the findings of a meta-analysis of 4 RCTs with MRAs in HF patients across the LVEF spectrum. According to Pardeep Jhund, these findings suggest that steroidal MRAs could be used in HFrEF and the non-steroidal MRA finerenone in HFmrEF/HFpEF.
This video was recorded during the ESC Congress 2024 in London, UK.
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the meta-analysis
Release date: 18 September 2024
ESC 2024 - Pardeep Jhund discusses the findings of a meta-analysis of 4 RCTs with MRAs in HF patients across the LVEF spectrum. According to Pardeep Jhund, these findings suggest that steroidal MRAs could be used in HFrEF and the non-steroidal MRA finerenone in HFmrEF/HFpEF.
This video was recorded during the ESC Congress 2024 in London, UK.
Pardeep Jhund is Professor of Cardiology and Epidemiology at the University of Glasgow and an honorary consultant cardiologist at the Queen Elizabeth University Hospital, Glasgow, UK.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of the meta-analysis
Release date: 18 September 2024
Stay current with the best on medical education
